SCHEMBL23154193

SCHEMBL23154193

CCc1cc(Nc2ncc(Br)c(Nc3ccc(-c4cnn(C)n4)cc3P(C)C)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23154142 0.94 EGFR (0.63) EGFR
SCHEMBL23154286 0.91 EGFR (0.64) EGFR
SCHEMBL23154042 0.91 EGFR (0.62) EGFR
SCHEMBL23154028 0.91 EGFR (0.63) EGFR
SCHEMBL23154353 0.90 EGFR (0.62) EGFR
SCHEMBL23154222 0.90 EGFR (0.62) EGFR
SCHEMBL23154262 0.90 EGFR (0.62) EGFR
SCHEMBL23154173 0.90 EGFR (0.65) EGFR
SCHEMBL23153737 0.89 EGFR (0.62) EGFR
SCHEMBL23154048 0.89 EGFR (0.65) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021057882-A1 EGFR INHIBITOR, COMPOSITION AND PREPARATION METHOD THEREFOR 贝达药业股份有限公司 2021-04-01 — — WO disclosed
Send feedback